Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality - insights from the german ablation registry
Event: ESC Congress 2021 - The Digital Experience
Topic: Catheter Ablation of Arrhythmias
Session: Congress committee e-posters choice in arrhythmias and device therapy
ESC 365 is supported by
